Article info
PDFSystematic review
Pegfilgrastim safety and efficacy on the last chemotherapy day versus the next: systematic review and meta-analysis
- Correspondence to Professor Xiaojian Zhang, The first affiliated hospital of zhengzhou university, Zhengzhou, Henan, China; zdypharm{at}163.com
Citation
Pegfilgrastim safety and efficacy on the last chemotherapy day versus the next: systematic review and meta-analysis
Publication history
- Received July 3, 2020
- Revision received November 16, 2020
- Accepted November 23, 2020
- First published May 27, 2021.
Article Versions
- Previous version (16 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.